Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc-fa(cp) rats

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 8, 1999, Pages 1527-1537

  Sharkey, Leslie C ^a   Holycross, Bethany J ^a   Park, Sonhee ^a   Shiry, Laura J ^a   Hoepf, Toni M ^a   McCune, Sylvia A ^a   Radin, Judith M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Veterinary Biosciences ^*  (United States)

Author keywords

Angiotensin converting enzyme; Atrial natriuretic peptide; Estradiol; Hypertension; Left ventricular fractional shortening; Left ventricular hypertrophy; Myosin isozyme; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ESTRADIOL; MESSENGER RNA; MYOSIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HORMONE BLOOD LEVEL; HYPERTENSION; KIDNEY; LIVER; NONHUMAN; OVARIECTOMY; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0033179164     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0985     Document Type: Article

References (37)

1. Adashi E.Y. Transdermal estrogen replacement. In: Adashi EY, Rock JA, Rosenwaks Z (eds). Reproductive Endocrinology, Surgery and Technology. Philadelphia: Lippincott Raven Publishers. 1784-1795. 1996.
2. Arai H., Nakao K., Saito Y., Morii N., Sugawara A., Yamada Y., Itoh H., Shiono S., Mukoyama M., Ohkubo H., Nakanishi S., Imura H. Augmented expression of atrial natriuretic peptide in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ Res. 62:1988;926-930.
3. Bachmann J., Wagner J., Haufe C., Wystrychowski A., Ciechanowicz A., Ganten D. Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats after ovariectomy. J Hypertens. 11(Suppl. 5):1993;S226-S227.
4. Bittner V. Hypertension in Women. Curr Op. Neph Hypertens. 92:1995;3431-3435.
5. Brosnihan K.B., Weddle D., Anthony M.S., Heise C., Li P., Ferrario C.M. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertension. 15:1997;719-726.
6. Burnham C., Hawelu-Johnson C., Frank B., Lynch K. Molecular cloning of rat renin cDNA and its gene. Proc Natl Acad Sci USA. 84:1987;602-609.
7. Buttrick P.M., Kaplan M., Leinwand L.A., Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol. 26:1994;61-67.
8. Chen Y., Naftilan A., Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rat. Hypertension. 19:1992;456-463.
9. Cheng D.Y., Gruelter C.A. Chronic estrogen alters contractile responsiveness to AII and norepinephrine in the female rat aorta. Eur J Pharm. 215:1992;171-176.
10. Chirgwin J., Przybyla A., MacDonald R., Rutter W. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
11. Davidson B., Rea C.D., Valenzuela G.J. Atrial natriÍuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome. Fertility and Sterility. 50:1988;743-746.
12. Eiff A.W., Lutz H.M., Kretzschmar R. The protective effect of estrogen on high blood pressure. Basic Res Cardiol. 80:1985;191-201.
13. Feldmer M., Kaling M., Takahashi S., Mullins J.J., Ganten D. Glucocorticoid and estrogen responsive elements in the 5′ flanking region of the rat angioÍtensinogen gene. J Hypertens. 9:1991;1005-1012.
14. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas H., Liang C., Kubo S.H., Rudin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation. 82:1990;1724-1729.
15. Fukamizu A., Nishi K., Cho T., Saitoh M., Nakayama K., Ohkubo H., Nakanishi S., Murakami K. Structure of the rat renin gene. J Mol Biol. 201:1988;443-450.
16. Geenen D.L., Malhotra A., Buttrick P.M. AngioÍtensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat. J Appl Phys. 81:1996;816-821.
17. Glembotski C., Oronzi M., Li X., Shields P., Hohnston P., Kallen R., Gibson R. The characterization of atrial natruiuretic peptide expression by primary cultures of atrial myocytes using an ANP-specific mono- clonal antibody and an ANP messenger ribonucleic acid probe. Endocrinol Biol. 121:1987;843-853.
18. Hoeg J.M., Willis L.R., Weinberger M.H. Estrogen attenuation of the development of hypertension in spontaneously hypertensive rats. Am J Physiol. 233:1977;H369-H373.
19. Hoh J., McGrath P., Hale P. Electrophoretic analysis of multiple forms of rat cardiac myosins; effects of hypophysectomy and thyroxin replacement. J Mol Cell Cardiol. 11:1978;1053-1078.
20. Holycross B., Summers B., Dunn R., McCune S. Plasma renin activity in heart failure prone (SHHF/Mcc- facp) rats. Am J Physiol. 273:1997;H228-H233.
21. Jesperson C.M. Hormone replacement therapy and high blood pressure. Am J Hypertens. 10:1997;366-367.
22. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 59:1975;365-372.
23. Lind T., Cameron E.C., Hunter W.M., Leon C., Moran P.G., Oxley Q., Gerrard J.A. Prospective controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obset Gyn. 86:1979;1-29.
24. McCune S., Park S., Radin M., Jurin R. SHHF/Mcc- facp rat model: a genetic model of congestive heart failure. In: Singal P, Dixon I, Beamish R, Dhalla R (eds). Mechanisms of Heart Failure. Kluwer Academic Publishers, 91-106. 1995.
25. Pines A., Fisman E.Z., Ayalon D., Drory Y., Averbuch M., Levo Y. Long-term effects of hormone replacement therapy on Doppler derived parameters of aortic flow in postmenopausal women. Chest. 102:1992;1496-1498.
26. Proudler A.J., Hasib-Ahmed A.I., Crook D., Fogelman I., Rymer J.M., Stevenson J.C. Hormone replacement therapy and ACE activity in postmenopausal women. Lancet. 346:1995;89-90.
27. Radin M.J., Jenkins J., McCune S.A., Hamlin R. Effects of enalapril and clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc- facp rats. J Cardiovasc Pharmacol. 19:1992;464-472.
28. Sabath D., Broome H., Prystowsky M. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene. 91:1990;185-191.
29. Sala C., Campise M., Ambroso G., Motta T., Zanchetti A., Morganti L. Atrial Natriuretic peptide and hemodynamic changes during normal human pregnancy. Hypertension. 25 (part 1):1995;631-636.
30. Schaible T.F., Malhotra A., Ciambrone C., Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res. 54:1984;38-49.
31. Scheuer J., Malhotra A., Schaible T.F., Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res. 61:1987;12-19.
32. Seltzer A., Pinto J.E.P., Viglione P.N., Correa F.M.A., Libertun C., Sutsum T., Steele M.K., Saavedra J.M. Estrogens regulate ACE and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology. 55:1992;460-467.
33. Sharkey L.C., Holycross B.J., Park S., McCune S.A., Hoversland R., Radin M.J. Effect of ovariectomy in heart failure-prone SHHF/Mcc- facp rats. Am J Physiol. 275:1998;R1968-R1976.
34. Snabes M.C., Payne J.P., Kopelen H.A., Dunn J.K., Young R., Zoghbi W.A. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized double blind, placebo controlled, crossover trial. Obstet Gyn. 89:1997;332-339.
35. Swartz J., Freeman R., Frishman W. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy on postmenopausal women. J Clin Pharmacol. 35:1995;1-16.
36. Utian W.H. Effect of postmenopausal estrogen therapy on diastolic blood pressure and body weight. Maturitas. 34:1978;3-8.
37. Yoshida K., Kohzuki M., Casley D.J., Johnston C.I. Angiotensin-converting enzyme inhibition and salt in experiment myocardial infarction. J Cardiovasc Pharmacol. 32:1998;357-365.